---
title: "Atreides doubled its Astera Labs stake to $875 million, then the stock fell 43%"
description: "The 13F, filed November 16, marks the stake at September 30; the stock has since fallen 43%. The next look at who owns it arrives with the mid-February filings, in the same month as the fourth-quarter results, so the September register is the one every rally trades against."
publisher: "The Inference"
section: "Chips"
published: 2026-11-18T14:47:44.999Z
modified: 2026-11-18T14:47:44.999Z
canonical: https://theinference.org/article/atreides-doubled-its-astera-labs-stake-to-875-million-then-the-stock-fell-43-by-mid-november
language: en
keywords: "Astera Labs, 13F Filings, Hedge Funds, Semiconductors, AI Hardware"
---

# Atreides doubled its Astera Labs stake to $875 million, then the stock fell 43%

> The 13F, filed November 16, marks the stake at September 30; the stock has since fallen 43%. The next look at who owns it arrives with the mid-February filings, in the same month as the fourth-quarter results, so the September register is the one every rally trades against.

## The September buyers are on the record

Atreides Management, a Boston firm managing $10.7 billion, doubled its [Astera Labs](https://theinference.org/markets/companies/astera-labs) holding to 2.46 million shares in the third quarter: $875 million at September 30, 8.1% of its disclosed US stock book and its second-largest line after a $4.1 billion [SpaceX](https://theinference.org/markets/companies/spacex) stake [1][2]. [The filing counts 2,459,106 shares exactly](https://www.sec.gov/Archives/edgar/data/1777813/000177781326000013/ATREIDES13F09302026v2.xml), and carries puts on a semiconductor ETF reported at $1.2 billion alongside the chip longs [2].

E20 Capital, with $1.21 billion of disclosed US stocks, filed November 13 showing a new 268,570-share stake worth $96 million, its third-largest line [3]. Whale Rock Capital, at nearly $13 billion, had sold all 1.57 million of its Astera shares by the same date [1].

## From $100 to $483 and back to $202

The shares ran from a closing low of $100.27 on March 30 to a 52-week high of $483.02 on June 30, then closed at $202.34 on November 16, down 43% since September 30 though still up 40% over twelve months [4][1]. The implied entry on the filings, reported value divided by share count, is about $356 [2].

*Chart: **Astera Labs peaked at $483 in June and closed near $212 on November 17** Line chart of Astera Labs' share price across four 2026 dates, showing the rise to a June peak and the fall back toward the March low.*

*Closing prices at dated marks: the 52-week closing low and high, and the November 16 and 17 closes. The 43% slide is measured from the September 30 close, the date the funds' third-quarter filings mark. Sources: Trefis [4], MarketScreener [9], TIKR [1]. [1][4][9]*

## If the shares are still there, the hole is $378 million

A 13F, the quarterly holdings snapshot funds file with the SEC, shows one day: no purchase prices, no current holdings [1]. Marked to the November 16 close, Atreides' line is worth about $498 million, a paper decline near $378 million on one position; E20's $96 million is nearer $54 million [1].

Passive money is leaving through the same door: [ETFs net sold $42.3 million of Astera on Friday, November 13](https://finance.yahoo.com/markets/stocks/articles/etfs-net-sellers-astera-labs-110229756.html), and $27.9 million the day before, led by the iShares Semiconductor fund SOXX cutting 281,295 shares, 7.66% of its stake [5]. The retreat is not universal: 31 ETFs bought against 10 sellers, and November 9's 13.7% rally drew $96.0 million of net ETF buying, the largest one-day move of the stretch [5].

*Chart: **ETF flows into Astera flipped from buying to net selling** Column chart of daily net ETF flows into Astera Labs shares across four November sessions, from large net buying to net selling.*

*Net dollar value of Astera Labs shares bought minus sold by ETFs, by session. Sources: GuruFocus [5]. [5]*

## The ramp is real, and the price still needs it

[Third-quarter revenue was $584.9 million](https://theinference.org/article/astera-labs-584-9-million-quarter-ran-53-through-one-customer-up-from-23-a-year-earlier), up 153.7% year over year, with the fourth quarter guided to $730 million to $750 million, about 27% more than the third at the midpoint [6][7]. Scorpio switches, now the largest product family, run above $1 billion annualized, with Scorpio X volume still shipping to two customers [6][3], [the concentration covered here on November 4](https://theinference.org/article/astera-labs-says-its-scorpio-x-series-exits-2026-above-a-1-billion-run-rate-one-customer-is-53).

*Chart: **Revenue grew sevenfold from mid-2024, and the fourth quarter is guided 27% higher** Line chart of Astera Labs quarterly revenue from the second quarter of 2024 through the third quarter of 2026, rising from $76.9 million to $584.9 million, with the fourth-quarter guide plotted at its $740 million midpoint and a $730 million to $750 million range.*

*Quarterly revenue in $ millions, as reported in Astera Labs' SEC filings. The final point is the midpoint of the company's fourth-quarter guide of $730 million to $750 million, with the guide's range shown. Sources: Astera Labs SEC filings [11]; fourth-quarter guidance [6]. [11][6]*

The stock still fell 8.8% on November 16, the day Astera and Hyve Solutions, TD SYNNEX's manufacturing arm, [said Hyve will build Orion's compute board, fabric tray and link board](https://markets.businessinsider.com/news/stocks/hyve-solutions-and-astera-labs-collaborate-to-bring-ai-inference-capacity-to-customers-faster-1036768951), company-tested at up to 89% more tokens per second and available from the first quarter of 2027 [8]. Tuesday brought a 4.6% bounce to $211.60 [9].

At $36.1 billion of market value, about 12 times annualized fourth-quarter revenue, the price still assumes the ramp lands [10].

## Both verdicts land in February

Twenty-five analysts carry a mean Buy and a $344.15 average target, 63% above Tuesday's close, after RBC cut its target to $400 from $500 and UBS to $290 [9]. That case is about the ramp; the register is its own problem. The next 13Fs are due mid-February, the same month as the fourth-quarter report, so who is still holding stays invisible until the evidence is in [9]. The September buyers are the sellers of any rally.

## Takeaway

Atreides doubled its Astera Labs stake to $875 million at the September 30 mark; marked to the November 16 close the line is worth about $498 million, and E20's $96 million stake is nearer $54 million. The next 13Fs land in mid-February, the same month as the fourth-quarter results, so the September register is what any rally trades against.

## Sources

1. [Yahoo Finance (Bobby Sankhagowit, TIKR), An $11 Billion Fund Dumps These 2 Stocks, 17 November 2026](https://finance.yahoo.com/markets/stocks/articles/11-billion-fund-dumps-2-191046915.html)
2. [SEC EDGAR, Atreides Management LP Form 13F-HR holdings table for quarter ended 30 September 2026, filed 16 November 2026](https://www.sec.gov/Archives/edgar/data/1777813/000177781326000013/ATREIDES13F09302026v2.xml)
3. [Yahoo Finance (Bobby Sankhagowit, TIKR), A $1.2 Billion Fund Dumps These 3 Stocks, 16 November 2026](https://finance.yahoo.com/markets/stocks/articles/1-2-billion-fund-dumps-144523364.html)
4. [Yahoo Finance (Trefis), Why Is Astera Labs Stock Falling Again?, 17 November 2026](https://finance.yahoo.com/markets/stocks/articles/why-astera-labs-stock-falling-144049614.html)
5. [Yahoo Finance (GuruFocus News), ETFs Are Net Sellers of Astera Labs (ALAB) on Friday, 17 November 2026](https://finance.yahoo.com/markets/stocks/articles/etfs-net-sellers-astera-labs-110229756.html)
6. [ad-hoc-news.de, Astera Labs stock keeps Q4 growth focus after board resignation, 11 November 2026](https://www.ad-hoc-news.de/boerse/news/corporate-news/astera-labs-stock-keeps-q4-growth-focus-after-board-resignation/70491783)
7. [Astera Labs quarterly revenue and margins from its SEC filings, retrieved 18 November 2026](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001736297)
8. [GlobeNewswire via Markets Insider, Hyve Solutions and Astera Labs Collaborate to Bring AI Inference Capacity to Customers Faster, 16 November 2026](https://markets.businessinsider.com/news/stocks/hyve-solutions-and-astera-labs-collaborate-to-bring-ai-inference-capacity-to-customers-faster-1036768951)
9. [MarketScreener (MT Newswires), Astera Labs, TD Synnex Unit Expand Collaboration to Speed Up AI Inference Deployments, 16 November 2026](https://www.marketscreener.com/news/astera-labs-td-synnex-unit-expand-collaboration-to-speed-up-ai-inference-deployments-ce785edfda88f724)
10. [Yahoo Finance (GuruFocus, Khac Phu Nguyen), Astera Labs Stocks Sink 6.95% Despite Guiding Revenue Up 26% Next Quarter, 16 November 2026](https://finance.yahoo.com/markets/stocks/articles/astera-labs-stocks-sink-6-174717881.html)
11. [Astera Labs, quarterly figures from its SEC filings, retrieved 18 November 2026](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001736297)


---

Atreides doubled its Astera Labs stake to $875 million, then the stock fell 43% — The Inference. Canonical: https://theinference.org/article/atreides-doubled-its-astera-labs-stake-to-875-million-then-the-stock-fell-43-by-mid-november
